Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Among the 8 articles that measured nutritional blood biomarkers, 5 reported improvements in at least one of them following treatment with PEN.23,31,39,56,72 These included increases in serum prealbumin,72 folic acid,39,56 ferritin,56 high-density lipoprotein,56 vitamin D3,23,39 vitamin B12,39 calcium,39 total protein,31 histidine,31 tryptophan,31 as well as a decrease in low-density lipoprotein.56 In 1 study, improvement in serum vitamin B12 achieved with 6-week 50% PEN with CDED was lost after another 6 weeks of 25% PEN with CDED.39 While most studies observed similar findings, 2 reported no improvements in nutritional blood biomarkers with PEN,33,73 and in a single cross-sectional study, PEN use was associated with lower serum selenium concentrations.74

Source: 3.3.2. PEN on nutritional outcomes of adults. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis

Source: Article title.

Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis

Systematic review · Journal of Crohn's & Colitis · 2025

Original publication title

Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis

Aleksandra Jatkowska; Bernadette White; Konstantinos Gkikas; John Paul Seenan; Jonathan MacDonald; Konstantinos Gerasimidis

© The Author(s) 2024. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Partial enteral nutrition may help in various aspects of Crohn’s disease management but much of the current evidence is of low quality. Well-designed randomized control trials are required to confirm findings from current literature and before clinical recommendations can be made.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Exclusive enteral nutrition is an established treatment for active Crohn’s disease but the role of partial enteral nutrition (PEN) in the broader management of the disease is less clear. This systematic review and meta-analysis reviewed the literature on the role of PEN in Crohn’s disease management.

Source: Background

Abstract: What methods does the paper describe?

This review was conducted following Cochrane recommendations. The protocol was registered on PROSPERO. Findings were reported following the PRISMA guidelines.

Source: Methods

Abstract: Results

Sixty-four articles were identified, of which 11 reported data from randomized control trials. Good quality evidence suggests that PEN may be used as a maintenance and induction therapy, particularly at high dosages and/or alongside exclusion diets. A higher dosage of PEN is associated with a lower risk of subsequent disease relapse, with benefits observed at intakes above 35% of energy requirements (35%-50% PEN: OR [95% confidence intervals (CI)]: 0.42 [0.27-0.65]; > 50% PEN: OR [95% CI]: 0.27 [0.08-0.88]). Low-quality evidence suggests that postoperative use of PEN may prevent disease recurrence or enhance treatment outcomes when used as adjunct therapy to biologics.

PEN can improve nutritional parameters, showing efficacy comparable to EEN in pediatric patients (weight: OR [95% CI]: −0.04 [−0.32, 0.25]). The effect of PEN on improving patients’ quality of life is comparable to that of EEN and anti-tumor necrosis factor alpha therapies.

Source: Results

Abstract: Conclusions

Partial enteral nutrition may help in various aspects of Crohn’s disease management but much of the current evidence is of low quality. Well-designed randomized control trials are required to confirm findings from current literature and before clinical recommendations can be made.

Source: Conclusions
Authors’ abstract

Abstract

Background

Exclusive enteral nutrition is an established treatment for active Crohn’s disease but the role of partial enteral nutrition (PEN) in the broader management of the disease is less clear. This systematic review and meta-analysis reviewed the literature on the role of PEN in Crohn’s disease management.

Methods

This review was conducted following Cochrane recommendations. The protocol was registered on PROSPERO. Findings were reported following the PRISMA guidelines.

Results

Sixty-four articles were identified, of which 11 reported data from randomized control trials. Good quality evidence suggests that PEN may be used as a maintenance and induction therapy, particularly at high dosages and/or alongside exclusion diets. A higher dosage of PEN is associated with a lower risk of subsequent disease relapse, with benefits observed at intakes above 35% of energy requirements (35%-50% PEN: OR [95% confidence intervals (CI)]: 0.42 [0.27-0.65]; > 50% PEN: OR [95% CI]: 0.27 [0.08-0.88]). Low-quality evidence suggests that postoperative use of PEN may prevent disease recurrence or enhance treatment outcomes when used as adjunct therapy to biologics.

PEN can improve nutritional parameters, showing efficacy comparable to EEN in pediatric patients (weight: OR [95% CI]: −0.04 [−0.32, 0.25]). The effect of PEN on improving patients’ quality of life is comparable to that of EEN and anti-tumor necrosis factor alpha therapies.

Conclusions

Partial enteral nutrition may help in various aspects of Crohn’s disease management but much of the current evidence is of low quality. Well-designed randomized control trials are required to confirm findings from current literature and before clinical recommendations can be made.

Publication and source details

Original title: Partial Enteral Nutrition in the Management of Crohn’s Disease: A Systematic Review and Meta-Analysis

Aleksandra Jatkowska; Bernadette White; Konstantinos Gkikas; John Paul Seenan; Jonathan MacDonald; Konstantinos Gerasimidis

Journal of Crohn's & Colitis · 2025

Corresponding author: Konstantinos Gerasimidis, Human Nutrition, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow G31 2ER, UK. Tel: 0141-956-0580; Email: Konstantinos.Gerasimidis@glasgow.ac.uk© The Author(s) 2024. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.2024https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Universtity of Glasgow and Nestle Health Science

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:26:49.987638+00:00

DOI: 10.1093/ecco-jcc/jjae177 · PMC12087569